The latest, from our erstwhile, now-serial anonymous contributor:
. . . .Merck has the following plan:
A development Center in Oss, with 486 R&D jobs.
This is a Development Center, including late stage Women's Health coregroup with 382 jobs.
104 R&D positions are kept alive in the Pharmaceutical test facility, and those positions become part of the Production Department and Facility Department.
547 jobs disappear as of July 1, 2011 under Merck Research Labs in Oss -- instead of the 1,000 announced layoffs in July 2010.
However, Merck forgot to count the 300 people that already left Merck and whose positions were never filled.
Greetz,
April 11, 2011 3:05 PM. . . .
Thanks -- and we will (with the aid of our readership) keep you posted.
2 comments:
An interesting article related by way of the mergers
http://www.pharmatimes.com/Article/11-04-13/M_A_strategy_has_failed_miserably_-_Burrill.aspx
remicade decision just out.
Post a Comment